Literature DB >> 27032711

Exercise-Induced Systemic Venous Hypertension in the Fontan Circulation.

Devaraj Navaratnam1, Samantha Fitzsimmons1, Michael Grocott1, Harry B Rossiter2, Yaso Emmanuel1, Gerard-Paul Diller3, Timothy Gordon-Walker4, Sandy Jack1, Nick Sheron1, John Pappachan1, Jayant Nick Pratap5, Joseph J Vettukattil6, Gruschen Veldtman7.   

Abstract

Increasingly end-organ injury is being demonstrated late after institution of the Fontan circulation, particularly liver fibrosis and cirrhosis. The exact mechanisms for these late phenomena remain largely elusive. Hypothesizing that exercise induces precipitous systemic venous hypertension and insufficient cardiac output for the exercise demand, that is, a possible mechanism for end-organ injury, we sought to demonstrate the dynamic exercise responses in systemic venous perfusion (SVP) and concurrent end-organ perfusion. Ten stable Fontan patients and 9 control subjects underwent incremental cycle ergometry-based cardiopulmonary exercise testing. SVP was monitored in the right upper limb, and regional tissue oxygen saturation was monitored in the brain and kidney using near-infrared spectroscopy. SVP rose profoundly in concert with workload in the Fontan group, described by the regression equation 15.97 + 0.073 watts per mm Hg. In contrast, SVP did not change in healthy controls. Regional renal (p <0.01) and cerebral tissue saturations (p <0.001) were significantly lower and decrease more rapidly in Fontan patients. We conclude that in a stable group of adult patients with Fontan circulation, high-intensity exercise was associated with systemic venous hypertension and reduced systemic oxygen delivery. This physiological substrate has the potential to contribute to end-organ injury.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27032711     DOI: 10.1016/j.amjcard.2016.02.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Vortex Flow in the Right Atrium Surrogates Supraventricular Arrhythmia and Thrombus After Atriopulmonary Connection-Type Fontan Operation: Vortex Flow Analysis Using Conventional Cine Magnetic Resonance Imaging.

Authors:  Yumi Shiina; Kei Inai; Tatsunori Takahashi; Yamato Shimomiya; Umiko Ishizaki; Kenji Fukushima; Michinobu Nagao
Journal:  Pediatr Cardiol       Date:  2017-11-02       Impact factor: 1.655

2.  Efficacy of Sports Club Activities on Exercise Tolerance Among Japanese Middle and High School Children and Adolescents After Fontan Procedure.

Authors:  Yoshihiko Kodama; Kyoko Koga; Ayako Kuraoka; Yuichi Ishikawa; Makoto Nakamura; Koichi Sagawa; Shiro Ishikawa
Journal:  Pediatr Cardiol       Date:  2018-05-21       Impact factor: 1.655

Review 3.  Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Brian W McCrindle; Shaji C Menon; Kurt R Schumacher; R Mark Payne; Jonathan Rhodes; Kimberly E McHugh; Daniel J Penny; Felicia Trachtenberg; Michelle S Hamstra; Marc E Richmond; Peter C Frommelt; Matthew D Files; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Am Heart J       Date:  2018-04-03       Impact factor: 4.749

4.  Results of the FUEL Trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Kurt R Schumacher; Jonathan Rhodes; Daniel J Penny; Christopher J Petit; Salil Ginde; Shaji C Menon; Seong-Ho Kim; Gi Beom Kim; Todd T Nowlen; Michael V DiMaria; Benjamin P Frischhertz; Jonathan B Wagner; Kimberly E McHugh; Brian W McCrindle; Amanda J Shillingford; Arash A Sabati; Anji T Yetman; Anitha S John; Marc E Richmond; Matthew D Files; R Mark Payne; Andrew S Mackie; Christopher K Davis; Shabana Shahanavaz; Kevin D Hill; Ruchira Garg; Jeffrey P Jacobs; Michelle S Hamstra; Stacy Woyciechowski; Kathleen A Rathge; Michael G McBride; Peter C Frommelt; Mark W Russell; Elaine M Urbina; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

Review 5.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 6.  Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations.

Authors:  Ashish H Shah; Shakeel A Qureshi; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2022-03-01       Impact factor: 2.931

7.  Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.

Authors:  Alexander R Opotowsky; Fernando R Baraona; Finnian R Mc Causland; Brittani Loukas; Elizabeth Landzberg; Michael J Landzberg; Venkata Sabbisetti; Sushrut S Waikar
Journal:  Heart       Date:  2016-09-26       Impact factor: 5.994

8.  Exercise Capacity and Predictors of Performance After Fontan: Results from the Pediatric Heart Network Fontan 3 Study.

Authors:  David J Goldberg; Victor Zak; Brian W McCrindle; Hua Ni; Russell Gongwer; Jonathan Rhodes; Robert P Garofano; Jonathan R Kaltman; Linda M Lambert; Lynn Mahony; Renee Margossian; Zebulon Z Spector; Richard V Williams; Andrew M Atz; Stephen M Paridon
Journal:  Pediatr Cardiol       Date:  2020-09-25       Impact factor: 1.655

Review 9.  Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.

Authors:  Derek L Tran; Hannah Gibson; Andrew J Maiorana; Charlotte E Verrall; David W Baker; Melanie Clode; David R Lubans; Diana Zannino; Andrew Bullock; Suzie Ferrie; Julie Briody; Peter Simm; Vishva Wijesekera; Michelle D'Almeida; Sally E Gosbell; Glen M Davis; Robert Weintraub; Anthony C Keech; Rajesh Puranik; Martin Ugander; Robert Justo; Dominica Zentner; Avik Majumdar; Leeanne Grigg; Jeff S Coombes; Yves d'Udekem; Norman R Morris; Julian Ayer; David S Celermajer; Rachael Cordina
Journal:  Front Pediatr       Date:  2022-01-06       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.